Crizotinib
SHARE
Molecule Summary
| Uses | Non-Small Cell Lung Cancer |
| Therapy | Anti-Neoplastic |
| Side Effects | Vision Changes, Nausea, Diarrhoea, Swelling |
Assurance
available
Regulated
Molecule Description
Crizotinib is an anticancer medication in a group known as receptor tyrosine kinase inhibitors (TKIs). It is used for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK (anaplastic lymphoma kinase)-positive. The medicine works by inhibiting specific abnormal enzymes that promote cancer cell growth and survival, blocking tumor proliferation and inducing cell death.
Treatment with Crizotinib requires regular medical supervision by an experienced oncologist. Because this medication can affect your heart rhythm, liver function, vision, and lung health, regular clinical monitoring will be recommended by your doctor. Blood tests, electrocardiograms (ECGs), and eye assessment as suggested by your doctor will be regularly monitored.
If you are receving this therapy your doctor will inform you about the potential risks, including visual disturbances, gastrointestinal effects, elevated liver enzymes, and changes in cardiac rhythm.
Uses
- Crizotinib is used to treat locally advanced or metastatic non-small-cell lung cancer (NSCLC)
Contraindications
When should one not use Crizotinib
- If you have a known hypersensitivity or severe allergic reaction to crizotinib or any of the inactive ingredients in the capsule formulation.
Side effects
Common side effects of this drug are:
- Visual disturbances (such as flashes of light, blurred vision, increased sensitivity to light, or floaters)
- Nausea, diarrhoea, vomiting, constipation, and decreased appetite
- Swelling (edema), particularly of the hands, feet, or ankles
- Fatigue
- Increased liver enzymes (transaminases)
- Dizziness and peripheral neuropathy (numbness or tingling)
- Taste disturbance (dysgeusia)
- Rash
- Low white blood cell counts, particularly neutropenia
- Joint or musculoskeletal pain
- Slow heart rate (bradycardia)
- Photosensitivity (increased sensitivity to sunlight)
- Serious heart rhythm problems, including QT interval prolongation
- Serious lung problems, such as interstitial lung disease or pneumonitis
- Severe liver problems, including life-threatening liver injury
- Severe or persistent vision problems, including partial or complete loss of vision
- Kidney problems, including renal cysts or changes in kidney function
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You develop a new or worsening cough, shortness of breath, or difficulty breathing, as these may be signs of lung inflammation (pneumonitis).
- You develop yellowing of the skin or eyes, dark urine, or other symptoms that may suggest liver problems.
- You notice new, persistent, or worsening changes in your vision. Report these promptly to your doctor or eye specialist.
- You develop a very slow heartbeat, especially if you also experience dizziness, fainting, or low blood pressure.
- Tell your doctor if you have heart problems, a history of QT prolongation, electrolyte abnormalities, or take medicines that can affect heart rhythm. You may need ECG and electrolyte monitoring.
- If you are being treated for ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour, report severe or persistent nausea, vomiting, diarrhoea, or abdominal symptoms promptly.
- Be cautious when driving or operating machinery if you experience visual disturbances such as blurred vision, flashes of light, or increased sensitivity to light.
- Keep all scheduled blood tests, liver-function tests, ECGs, and other monitoring appointments recommended by your doctor.
- Report any new or worsening breathing problems promptly, as serious lung inflammation can occur with crizotinib.
- Report severe or persistent changes in vision promptly.
- Tell your healthcare providers that you are taking crizotinib and follow their instructions regarding medical or eye examinations.
- If you develop persistent nausea or diarrhoea, inform your doctor early and maintain adequate fluid intake as advised.
Mode of Action
How Does It Work?
Crizotinib is a targeted cancer medicine that blocks proteins called ALK, ROS1, and MET, which can send signals that help cancer cells grow and multiply. In some cancers, changes in these genes produce abnormal proteins that promote uncontrolled cell growth. Crizotinib blocks these signals, helping to slow or stop cancer growth and may cause some cancer cells to die.
Interactions
Interactions with other medicines
- Ketoconazole, clarithromycin, and ritonavir may increase crizotinib levels and the risk of side effects. These medicines should generally be avoided with crizotinib unless specifically advised by your doctor.
- Rifampicin, carbamazepine, and St. John’s wort may reduce crizotinib levels and make it less effective. These medicines should generally be avoided with crizotinib.
- Tell your doctor if you take medicines that can affect heart rhythm or slow your heartbeat, as crizotinib can prolong the QT interval and cause a slow heart rate.
- Some medicines that are affected by the CYP3A enzyme may interact with crizotinib and require careful monitoring or dose adjustment.
- Tell your doctor about all prescription and over-the-counter medicines, vitamins, supplements, and herbal products you take. Avoid grapefruit and grapefruit juice while taking crizotinib.
Interactions with food items
Crizotinib can generally be taken with or without food. Avoid grapefruit, grapefruit juice, and products containing grapefruit extract while taking crizotinib, as they may increase the amount of crizotinib in your blood and increase the risk of side effects.
Dosage
Overdose
If an overdose is suspected, contact your doctor immediately or seek emergency medical care. There is no specific antidote. Treatment focuses on managing symptoms and close medical monitoring.
Missed a Dose
Do not take two doses at the same time to make up for a missed dose. If you are unsure that you have missed a dose contact your doctor.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
References:
- DailyMed. Crizotinib prescribing information. 2026 [Cited 17th Sep 2026]
- electronic medicines compendium (emc). Crizotinib Summary of Product Characteristics. 2026 [Cited 17th Sep 2026]
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. 2026 [Cited 17th Sep 2026]
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









